Guidance document : cancellation of a drug identification number (DIN) and notification of discontinuation of sales. : H13-9/10-2018E-PDF
"A Drug Identification Number (DIN) serves as an identifier of a drug and its associated characteristics. The assignment of a DIN indicates that a drug has undergone a successful Health Canada review process and is currently authorized for sale in Canada. The purpose of this guidance document is to provide assistance in interpreting sections C.01.014.6 and C.01.014.7 of the Regulations for the cancellation of a DIN and the notification to Health Canada of the discontinuation of the sale of a drug"--P. 7.
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.854395&sl=1
| Ministère/Organisme | Canada. Health Canada. |
|---|---|
| Titre | Guidance document : cancellation of a drug identification number (DIN) and notification of discontinuation of sales. |
| Variante du titre | Cancellation of a drug identification number (DIN) and notification of discontinuation of sales Cancellation of a DIN & notification of discontinuation of sales |
| Type de publication | Monographie |
| Langue | [Anglais] |
| Autres langues publiées | [Français] |
| Format | Électronique |
| Document électronique | |
| Note(s) | Issued also in French under title: Ligne directrice : annulation d’une identification numérique d’une drogue (DIN) et avis de cessation de la vente d’une drogue. Cover title. "Date adopted: 2017/03/14. Revision date: 2018/06/13. Effective date: 2018/06/13." "Publication date: June 2018." Issued also in HTML format. Includes bibliographical references. |
| Information sur la publication | Ottawa : Health Canada, 2018. |
| Description | 18 p. |
| ISBN | 9780660260105 |
| Numéro de catalogue |
|
| Numéro de catalogue du ministère | 170513 |
| Descripteurs | Drugs Product elimination Handbooks |